CliffBio
small molecule

OMEPRAZOLE

OMEPRAZOLE

Loss of exclusivity—loss of exclusivity
CompanyImpax Laboratories →See this company's full patent-cliff portfolio

Drug detail

Brand nameOMEPRAZOLE
Active ingredientOMEPRAZOLE
Strength10MG
Dosage formCAPSULE, DELAYED REL PELLETS
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2007
Marketing statusRX

More from Impax Laboratories

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

OMEPRAZOLE patent cliff — loss of exclusivity — | CliffBio